Search results :

Amprenavir

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: J05AE05

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6
Hyperglycaemia Hyperglycaemia uncommon, 41% - 58% x x x x x x
Hypertriglyceridaemia Hypertriglyceridaemia common, 40% - 56% x x x
Blood triglycerides increased Hypertriglyceridaemia common, 40% - 56% x x x
Diarrhoea Loose stools common, 32% - 60% x x x
Diarrhoea very common, 5% - 60% x x x x x x
Flatulence Flatulence very common x
Inflammation Inflammation very common x
Opportunistic infection Opportunistic infection very common x
Vomiting Vomiting very common, 2% - 24% x x x x x x
Hypercholesterolaemia Hypercholesterolaemia postmarketing — 9% - 15% x x x x x x
Paraesthesia Paraesthesia 1% - 31% x x
Dermatitis Rash very common, 2% - 20% x x x x x
Rash Rash very common, 2% - 20% x x x x x
Affective disorder Affective disorder common, 4% - 13% x x x
Decreased appetite Anorexia common x
Depression Depressive disorder common x
Dysthymic disorder Depressive disorder common x
Gastrointestinal disorder Gastrointestinal disorder common x
Gastrointestinal symptom NOS x
Nausea Nausea very common, 4% - 7% x x x x x x
Tremor Tremor common x
Amylase increased Amylase increased common x
Abdominal discomfort Abdominal discomfort common x
Hepatobiliary disease Hepatobiliary disease common x
Sleep disorder Sleep disorder common x
Fat redistribution Fat redistribution common x x
Paraesthesia oral Perioral paraesthesia common x
Paraesthesia oral postmarketing x x x
Headache Headache very common, 2% - 4% x x x x x
Transaminases increased Transaminases increased uncommon, common x
Asthenia Fatigue very common, 1% - 2% x x x x x
Fatigue Fatigue very common, 1% - 2% x x x x x
Abdominal pain Abdominal pain common, 0% - 2% x x x x x x
Gastrointestinal pain Abdominal pain common, 0% - 2% x x x x x x
Hyperbilirubinaemia Hyperbilirubinaemia uncommon x
Angioedema Angioedema postmarketing, uncommon x x x x
Cardiac disorder Cardiac disorder postmarketing x x x
Myocardial infarction Myocardial infarction postmarketing x x x
Acute coronary syndrome Myocardial infarction postmarketing x x x
Nervous system disorder Nervous system disorder postmarketing, common x x x x
Erythema multiforme Stevens-Johnson syndrome rare x x x
Stevens-Johnson syndrome Stevens-Johnson syndrome rare x x x
Malnutrition Malnutrition postmarketing x x x x
Skin disorder Unspecified disorder of skin and subcutaneous tissue postmarketing x x x x
Nephrolithiasis Nephrolithiasis postmarketing x x x
Mental disorder Mental disorder x
Connective tissue disorder Connective tissue disorder x
Diabetes mellitus Diabetes mellitus x x
Hepatitis B Hepatitis B x
Breast enlargement Hypertrophy of breast x
Insulin resistance Insulin resistance x
Lipodystrophy acquired Lipodystrophy x
Myositis Myositis x
Neutropenia Neutropenia x x
Pruritus Pruritus x x x x x x
Rhabdomyolysis Rhabdomyolysis x
Blood creatine phosphokinase increased Creatine phosphokinase increased x
Liver function test abnormal Liver function test abnormal x
Aspartate aminotransferase increased Aspartate aminotransferase increased x x x
Alanine aminotransferase increased Alanine aminotransferase increased x x x
Myalgia Myalgia x
Musculoskeletal discomfort Myalgia x
Discomfort Discomfort x
Lipohypertrophy Buffalo hump x x x
Abdominal symptom Abdominal symptom x
Hyperlactacidaemia Hyperlactacidaemia x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

AMPRENAVIR

Side effects:20
Source:FDA Structured Product Label

AMPRENAVIR

Side effects:20
Source:FDA Structured Product Label

AMPRENAVIR

Side effects:21
Source:FDA Structured Product Label

AMPRENAVIR / AGENERASE

Side effects:16
Source:FDA

amprenavir / Agenerase

Side effects:21
Source:FDA

amprenavir / amprenavir

Side effects:48
Source:EMA

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label